| Rt Medical Llc | |
| 3524 Central Pike, Ste 310, Hermitage, Tennessee 37076 | |
| (615) 469-7299 |
| Name | Rt Medical Llc |
|---|---|
| Organization Name | Rt Medical Llc |
| Location | 3524 Central Pike, Ste 310, Hermitage, Tennessee 37076 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (615) 469-7299 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
"Talent Management in Healthcare," a recent study by Aberdeen Group, a Harte-Hanks Company, reveals that although healthcare organizations are still struggling with the lack of qualified candidates in the talent market, the primary focus has been on developing and retaining talent. Performance management, engagement, and succession planning are the top strategic emphases for these organizations.
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration authorization in April, following a clinical trial in primary care offices.
CytoSorbents Corporation, a leader in critical care immunotherapy commercializing its CytoSorb extracorporeal cytokine adsorber to control deadly inflammation using blood purification, today announced an exclusive multi-year distribution agreement with Hoang Long Pharma, a medical distributor in Vietnam specializing in the distribution of innovative pharmaceuticals, biologics, and devices to treat patients suffering from critical illnesses, immunologic disorders and deficiencies, and infections.
Arena Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Arena also reported earlier today top-line results from its lorcaserin Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) trial.
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.
› Verified 6 days ago
| NPI Number | 1548360464 |
| Organization Name | RT MEDICAL LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1241 Robinson Rd, Old Hickory, TN 37138 |
| Phone Number | 615-469-7299 |
News Archive
"Talent Management in Healthcare," a recent study by Aberdeen Group, a Harte-Hanks Company, reveals that although healthcare organizations are still struggling with the lack of qualified candidates in the talent market, the primary focus has been on developing and retaining talent. Performance management, engagement, and succession planning are the top strategic emphases for these organizations.
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration authorization in April, following a clinical trial in primary care offices.
CytoSorbents Corporation, a leader in critical care immunotherapy commercializing its CytoSorb extracorporeal cytokine adsorber to control deadly inflammation using blood purification, today announced an exclusive multi-year distribution agreement with Hoang Long Pharma, a medical distributor in Vietnam specializing in the distribution of innovative pharmaceuticals, biologics, and devices to treat patients suffering from critical illnesses, immunologic disorders and deficiencies, and infections.
Arena Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Arena also reported earlier today top-line results from its lorcaserin Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) trial.
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.
› Verified 6 days ago
News Archive
"Talent Management in Healthcare," a recent study by Aberdeen Group, a Harte-Hanks Company, reveals that although healthcare organizations are still struggling with the lack of qualified candidates in the talent market, the primary focus has been on developing and retaining talent. Performance management, engagement, and succession planning are the top strategic emphases for these organizations.
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration authorization in April, following a clinical trial in primary care offices.
CytoSorbents Corporation, a leader in critical care immunotherapy commercializing its CytoSorb extracorporeal cytokine adsorber to control deadly inflammation using blood purification, today announced an exclusive multi-year distribution agreement with Hoang Long Pharma, a medical distributor in Vietnam specializing in the distribution of innovative pharmaceuticals, biologics, and devices to treat patients suffering from critical illnesses, immunologic disorders and deficiencies, and infections.
Arena Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Arena also reported earlier today top-line results from its lorcaserin Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) trial.
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.
› Verified 6 days ago
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5651 Frist Blvd, Hermitage, Tennessee 37076 Phone: (615) 871-9800 | |
Hermitage Eye Care Pllc Type: Medicare Supplier Location: 232 Jackson Meadows Drive, Hermitage, Tennessee 37076 Phone: (615) 889-2274 | |
Kroger Pharmacy L-518 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5544 Old Hickory Blvd, Hermitage, Tennessee 37076 Phone: (615) 883-0332 | |
Kroger Pharmacy L-866 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4400 Lebanon Pike, Hermitage, Tennessee 37076 Phone: (615) 883-4259 | |
Publix Pharmacy #0182 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4670 Lebanon Pike, Hermitage, Tennessee 37076 Phone: (615) 874-2216 |